Recent research has illuminated the expanding potential of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, which were initially approved for diabetes management...
By 193cc Agency CouncilSeptember 5, 2024The use of GLP-1 medications, such as semaglutide, for weight loss has surged significantly over the past decade. However, a recent study indicates...
By 193cc Agency CouncilJuly 23, 2024A recent study published in the journal JAMA Network indicates that medications such as Ozempic and Wegovy, popular for weight loss, may lead...
By 193cc Agency CouncilJune 26, 2024A comprehensive study recently conducted has shed new light on the potential correlation between GLP-1 medications like Ozempic and Wegovy and the risk...
By 193cc Agency CouncilApril 10, 2024